Q2 2024 Viemed Healthcare Inc Earnings Call Transcript
Key Points
- Viemed Healthcare Inc (VMD) achieved a record net revenue of $55 million for the second quarter of 2024, marking a 27% increase over the previous year.
- The company successfully integrated East Alabama HomeMed, expanding its workforce to 1,121 employees and setting a framework for future joint venture opportunities.
- Sales force restructuring initiatives led to a 15% increase in average monthly setups per sales rep, enhancing overall sales performance.
- The company's sleep business experienced strong organic growth, now representing 15% of the revenue mix, with a double-digit quarterly growth rate.
- Viemed Healthcare Inc (VMD) is leveraging technology and machine learning tools to improve processes, enhance patient care, and optimize claim processes.
- The Philips recall of older ventilators, while presenting an opportunity, requires careful management to replace affected devices without impacting cash flows.
- General and administrative expenses increased to $26.5 million, up from $20.6 million in the second quarter of 2023, though they decreased as a percentage of revenue.
- The company faced a $2.2 million impact from reserves related to a former vendor's bankruptcy and an impairment on an investment.
- The Change Healthcare cybersecurity issue led to increased accounts receivable, with approximately $4 million still outstanding as of June 30.
- Despite strong financial performance, the stock market's perception of the sector, potentially influenced by the GLP-1 craze, has led to a low EBITDA multiple for Viemed Healthcare Inc (VMD).
Good day, ladies and gentlemen, and welcome to the VieMed second-quarter 2024 earnings call. Our host for today's call is Todd Zehnder, Chief Operating Officer. (Operator Instructions)
I would like to now turn the call over to your host, Mr. Zehnder. You may begin.
Hi. Thank you, and good morning, everyone. We appreciate you joining us today.
I'm excited to share that -- please note that our remarks in this conference call may include forward-looking statements under the US federal securities laws or forward-looking information under applicable Canadian Securities legislation, which we collectively refer to as forward-looking statements. Such statements reflect the company's current views and intentions with respect to future results or events and are subject to certain risks and uncertainties, which could cause actual results or events to vary from those indicated in forward-looking statements.
Examples of such risks and uncertainties are discussed in our
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
